200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 5053-08-7

5053-08-7

5053-08-7 | 2-OXAZOLIDINONE-5-SPIRO-4'-[N-(2-PHENYLETHYL)PIPERIDINE] HYDROCHLORIDE

CAS No: 5053-08-7 Catalog No: AG00DEIW MDL No:MFCD00133315

Product Description

Catalog Number:
AG00DEIW
Chemical Name:
2-OXAZOLIDINONE-5-SPIRO-4'-[N-(2-PHENYLETHYL)PIPERIDINE] HYDROCHLORIDE
CAS Number:
5053-08-7
Molecular Formula:
C15H21ClN2O2
Molecular Weight:
296.7924
MDL Number:
MFCD00133315
IUPAC Name:
8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one;hydrochloride
InChI:
InChI=1S/C15H20N2O2.ClH/c18-14-16-12-15(19-14)7-10-17(11-8-15)9-6-13-4-2-1-3-5-13;/h1-5H,6-12H2,(H,16,18);1H
InChI Key:
FIKFLLIUPUVONI-UHFFFAOYSA-N
SMILES:
O=C1NCC2(O1)CCN(CC2)CCc1ccccc1.Cl
EC Number:
225-752-9
UNII:
832NBX878V
NSC Number:
757825

Properties

Complexity:
318  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
296.129g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
296.795g/mol
Monoisotopic Mass:
296.129g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
41.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Large-volume injection of sample diluents not miscible with the mobile phase as an alternative approach in sample preparation for bioanalysis: an application for fenspiride bioequivalence. Bioanalysis 20110901
[The use of eurespal for the treatment of chronic laryngitis]. Vestnik otorinolaringologii 20110101
[The estimation of clinical efficacy of eurespal in the postoperative period following surgical intervention on paranasal sinuses]. Vestnik otorinolaringologii 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
[Experience in using erespal in the treatment of acute respiratory diseases in children in outpatient practice]. Vestnik otorinolaringologii 20100101
[Pathogenetic correction of postoperative inflammation in modern rhinosurgery]. Vestnik otorinolaringologii 20100101
[Efficiency of combination therapy for acute otitis media]. Vestnik otorinolaringologii 20100101
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
[Experience with fenspiride in a rhinosurgeon's practice]. Vestnik otorinolaringologii 20090101
[Pathogenetic therapy for inflammatory diseases of the middle ear]. Vestnik otorinolaringologii 20090101
[Clinicofunctional condition and quality of life in patients with chronic obstructive pulmonary disease before and after outpatient treatment with fenspiride]. Terapevticheskii arkhiv 20080101
[Hearing rehabilitation in patients with acute otitis media treated with fenspiride]. Vestnik otorinolaringologii 20080101
[The effectiveness of fenspiride in the treatment of patients with chronic obstructive pulmonary disease]. Klinicheskaia meditsina 20070101
[New pharmaceuticals in treatment of chronic dust bronchitis]. Klinicheskaia meditsina 20070101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
[Erespal in combined therapy of acute rhinosinusitis]. Vestnik otorinolaringologii 20060101
Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease. Clinical drug investigation 20060101
[Anti-inflammatory therapy of paranasal sinuses diseases]. Vestnik otorinolaringologii 20060101
[The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050801
[Fenspiride in patients with acute bronchitis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050701
[Usefulness of fenspiride in the treatment of acute otitis media in children]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050601
[Effectiveness and tolerance of fenspiride treatment in chronic sinusitis. Results of the Polish multicenter study]. Otolaryngologia polska = The Polish otolaryngology 20050101
[Potential of antiinflammatory therapy in patients with chronic obstructive lung disease]. Klinicheskaia meditsina 20050101
[Acute intoxication with fenspiride]. Przeglad lekarski 20040101
[Erespal effectiveness in exudative otitis media]. Vestnik otorinolaringologii 20030101
[Fenspiride-a new alternative on the therapy of obstructive lung disease]. Pneumologia (Bucharest, Romania) 20030101
[Bronchial inflammation during chronic bronchitis, importance of fenspiride]. Presse medicale (Paris, France : 1983) 20020901
[ENT inflammation and importance of fenspiride]. Presse medicale (Paris, France : 1983) 20020901
Detection of fenspiride and identification of in vivo metabolites in horse body fluids by capillary gas chromatography-mass spectrometry: administration, biotransformation and urinary excretion after a single oral dose. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020205
[Experience in treating patients with chronic obstructive bronchitis with fenspirid]. Terapevticheskii arkhiv 20020101
[Effectiveness of fenspiride in patients with chronic obstructive bronchitis]. Klinicheskaia meditsina 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.